Year |
Citation |
Score |
2022 |
Kapri D, Vadodaria KC, Rommelfanger KS, Ogbonmwan YE, Liles LC, Fernandes-Thomas KA, Salvi SS, Husain BFA, Weinshenker D, Vaidya VA. Genetic loss of norepinephrine does not alter adult hippocampal neurogenesis in dopamine beta-hydroxylase deficient mice. Ibro Neuroscience Reports. 13: 420-425. PMID 36386600 DOI: 10.1016/j.ibneur.2022.10.010 |
0.494 |
|
2021 |
Moss AU, Li ZR, Rommelfanger KS. Assessing the Perceived Value of Neuroethics Questions and Policy to Neuro-Entrepreneurs. Frontiers in Neuroscience. 15: 702019. PMID 34720850 DOI: 10.3389/fnins.2021.702019 |
0.542 |
|
2021 |
Shen FX, Wolf SM, Bhavnani S, Deoni S, Elison JT, Fair D, Garwood M, Gee MS, Geethanath S, Kay K, Lim KO, Lockwood-Estrin G, Luciana M, Peloquin D, Rommelfanger K, et al. Emerging Ethical Issues Raised by Highly Portable MRI Research in Remote and Resource-Limited International Settings. Neuroimage. 118210. PMID 34062266 DOI: 10.1016/j.neuroimage.2021.118210 |
0.303 |
|
2020 |
Adams A, Albin S, Amunts K, Asakawa T, Bernard A, Bjaalie JG, Chakli K, Deshler JO, Koninck YD, Ebell CJ, Egan G, Hale ME, Häusser M, Jeong SJ, Illes J, ... ... Rommelfanger KS, et al. Erratum: International Brain Initiative: An Innovative Framework for Coordinated Global Brain Research Efforts (Neuron (2020) 105(2) (212–216), (S0896627320300027), (10.1016/j.neuron.2020.01.002)) Neuron. 105. PMID 32135092 DOI: 10.1016/J.Neuron.2020.02.022 |
0.388 |
|
2020 |
Adams A, Albin S, Amunts K, Asakawa T, Bernard A, Bjaalie JG, Chakli K, Deshler JO, Koninck YD, Ebell CJ, Egan G, Hale ME, Häusser M, Jeong S, Illes J, ... ... Rommelfanger KS, et al. International Brain Initiative: An Innovative Framework for Coordinated Global Brain Research Efforts Neuron. 105: 212-216. PMID 31972144 DOI: 10.1016/J.Neuron.2020.01.002 |
0.411 |
|
2019 |
Hendriks S, Grady C, Ramos KM, Chiong W, Fins JJ, Ford P, Goering S, Greely HT, Hutchison K, Kelly ML, Kim SYH, Klein E, Lisanby SH, Mayberg H, Maslen H, ... ... Rommelfanger K, et al. Ethical Challenges of Risk, Informed Consent, and Posttrial Responsibilities in Human Research With Neural Devices: A Review. Jama Neurology. PMID 31621797 DOI: 10.1001/Jamaneurol.2019.3523 |
0.384 |
|
2019 |
Ramos KM, Grady C, Greely HT, Chiong W, Eberwine J, Farahany NA, Johnson LSM, Hyman BT, Hyman SE, Rommelfanger KS, Serrano EE, Churchill JD, Gordon JA, Koroshetz WJ. The NIH BRAIN Initiative: Integrating Neuroethics and Neuroscience. Neuron. 101: 394-398. PMID 30731065 DOI: 10.1016/J.Neuron.2019.01.024 |
0.392 |
|
2018 |
Ramos KM, Rommelfanger KS, Greely HT, Koroshetz WJ. Neuroethics and the NIH BRAIN Initiative. Journal of Responsible Innovation. 5: 122-130. PMID 30854409 DOI: 10.1080/23299460.2017.1319035 |
0.399 |
|
2018 |
Greely HT, Grady C, Ramos KM, Chiong W, Eberwine J, Farahany NA, Johnson LSM, Hyman BT, Hyman SE, Rommelfanger KS, Serrano EE. Neuroethics Guiding Principles for the NIH BRAIN Initiative. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 38: 10586-10588. PMID 30541767 DOI: 10.1523/Jneurosci.2077-18.2018 |
0.367 |
|
2018 |
Rommelfanger KS, Jeong SJ, Ema A, Fukushi T, Kasai K, Ramos KM, Salles A, Singh I. Neuroethics Questions to Guide Ethical Research in the International Brain Initiatives. Neuron. 100: 19-36. PMID 30308169 DOI: 10.1016/J.Neuron.2018.09.021 |
0.455 |
|
2017 |
Wolpe PR, Rommelfanger KS. Ethical principles for the use of human cellular biotechnologies. Nature Biotechnology. 35: 1050-1058. PMID 29121024 DOI: 10.1038/Nbt.4007 |
0.338 |
|
2017 |
Vadodaria KC, Yanpallewar SU, Vadhvani M, Toshniwal D, Liles LC, Rommelfanger KS, Weinshenker D, Vaidya VA. Noradrenergic regulation of plasticity marker expression in the adult rodent piriform cortex. Neuroscience Letters. PMID 28237805 DOI: 10.1016/J.Neulet.2017.02.060 |
0.512 |
|
2015 |
Purcell RH, Rommelfanger KS. Internet-based brain training games, citizen scientists, and big data: ethical issues in unprecedented virtual territories. Neuron. 86: 356-9. PMID 25905809 DOI: 10.1016/J.Neuron.2015.03.044 |
0.345 |
|
2014 |
Trimper JB, Wolpe PR, Rommelfanger KS. When "I" becomes "We": ethical implications of emerging brain-to-brain interfacing technologies. Frontiers in Neuroengineering. 7: 4. PMID 24575002 DOI: 10.3389/Fneng.2014.00004 |
0.409 |
|
2013 |
Hammerschmidt T, Kummer MP, Terwel D, Martinez A, Gorji A, Pape HC, Rommelfanger KS, Schroeder JP, Stoll M, Schultze J, Weinshenker D, Heneka MT. Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice. Biological Psychiatry. 73: 454-63. PMID 22883210 DOI: 10.1016/J.Biopsych.2012.06.013 |
0.526 |
|
2012 |
Hadipour-Niktarash A, Rommelfanger KS, Masilamoni GJ, Smith Y, Wichmann T. Extrastriatal D2-like receptors modulate basal ganglia pathways in normal and Parkinsonian monkeys. Journal of Neurophysiology. 107: 1500-12. PMID 22131382 DOI: 10.1152/Jn.00348.2011 |
0.314 |
|
2010 |
Rommelfanger KS, Wichmann T. Extrastriatal dopaminergic circuits of the Basal Ganglia. Frontiers in Neuroanatomy. 4: 139. PMID 21103009 DOI: 10.3389/Fnana.2010.00139 |
0.315 |
|
2010 |
Yanpallewar SU, Fernandes K, Marathe SV, Vadodaria KC, Jhaveri D, Rommelfanger K, Ladiwala U, Jha S, Muthig V, Hein L, Bartlett P, Weinshenker D, Vaidya VA. Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 1096-109. PMID 20089918 DOI: 10.1523/Jneurosci.2309-09.2010 |
0.519 |
|
2009 |
Rommelfanger KS, Mitrano DA, Smith Y, Weinshenker D. Light and electron microscopic localization of alpha-1 adrenergic receptor immunoreactivity in the rat striatum and ventral midbrain. Neuroscience. 158: 1530-40. PMID 19068224 DOI: 10.1016/J.Neuroscience.2008.11.019 |
0.521 |
|
2007 |
Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Miller GW, Weinshenker D. Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proceedings of the National Academy of Sciences of the United States of America. 104: 13804-9. PMID 17702867 DOI: 10.1073/Pnas.0702753104 |
0.539 |
|
2007 |
Rommelfanger KS, Weinshenker D. Norepinephrine: The redheaded stepchild of Parkinson's disease. Biochemical Pharmacology. 74: 177-90. PMID 17416354 DOI: 10.1016/J.Bcp.2007.01.036 |
0.545 |
|
2004 |
Rommelfanger KS, Weinshenker D, Miller GW. Reduced MPTP toxicity in noradrenaline transporter knockout mice. Journal of Neurochemistry. 91: 1116-24. PMID 15569255 DOI: 10.1111/J.1471-4159.2004.02785.X |
0.552 |
|
Low-probability matches (unlikely to be authored by this person) |
2015 |
Rommelfanger KS, Johnson LSM. What Lies Ahead for Neuroethics Scholarship and Education in Light of the Human Brain Projects? Ajob Neuroscience. 6: 1-3. DOI: 10.1080/21507740.2015.1000158 |
0.299 |
|
2017 |
Rommelfanger KS, Factor SA, LaRoche S, Rosen P, Young R, Rapaport MH. Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the Future. Frontiers in Neurology. 8: 106. PMID 28424653 DOI: 10.3389/Fneur.2017.00106 |
0.293 |
|
2013 |
Rommelfanger KS. Opinion: A role for placebo therapy in psychogenic movement disorders. Nature Reviews. Neurology. 9: 351-6. PMID 23628738 DOI: 10.1038/Nrneurol.2013.65 |
0.286 |
|
2023 |
O'Shaughnessy MR, Johnson WG, Tournas LN, Rozell CJ, Rommelfanger KS. Neuroethics guidance documents: principles, analysis, and implementation strategies. Journal of Law and the Biosciences. 10: lsad025. PMID 37901886 DOI: 10.1093/jlb/lsad025 |
0.285 |
|
2014 |
Galvan A, Hu X, Rommelfanger KS, Pare JF, Khan ZU, Smith Y, Wichmann T. Localization and function of dopamine receptors in the subthalamic nucleus of normal and parkinsonian monkeys. Journal of Neurophysiology. 112: 467-79. PMID 24760789 DOI: 10.1152/Jn.00849.2013 |
0.278 |
|
2011 |
Rommelfanger KS, Boshears P. Ethical use of neuroscience Ajob Neuroscience. 2: 19-21. DOI: 10.1080/21507740.2011.559919 |
0.268 |
|
2019 |
Ahlgrim NS, Garza K, Hoffman C, Rommelfanger KS. Prodromes and Preclinical Detection of Brain Diseases: Surveying the Ethical Landscape of Predicting Brain Health. Eneuro. PMID 31221862 DOI: 10.1523/ENEURO.0439-18.2019 |
0.262 |
|
2013 |
Rommelfanger KS. Attitudes on Mind Over Matter: Physician Views on the Role of Placebo in Psychogenic Disorders Ajob Neuroscience. 4: 9-15. DOI: 10.1080/21507740.2013.796327 |
0.254 |
|
2020 |
Rommelfanger KS. Reflecting on a Neuroethics Roadmap in a Global Crisis Ajob Neuroscience. 11: 131-134. DOI: 10.1080/21507740.2020.1786311 |
0.248 |
|
2020 |
Pick S, Anderson DG, Asadi-Pooya AA, Aybek S, Baslet G, Bloem BR, Bradley-Westguard A, Brown RJ, Carson AJ, Chalder T, Damianova M, David AS, Edwards MJ, Epstein SA, Espay AJ, ... ... Rommelfanger KS, et al. Outcome measurement in functional neurological disorder: a systematic review and recommendations. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32111637 DOI: 10.1136/Jnnp-2019-322180 |
0.241 |
|
2019 |
Rommelfanger KS, Jeong SJ, Montojo C, Zirlinger M. Neuroethics: Think Global. Neuron. 101: 363-364. PMID 30731058 DOI: 10.1016/J.Neuron.2019.01.041 |
0.239 |
|
2015 |
Sarrett JC, Rommelfanger KS. Commentary: Attention to Eyes Is Present but in Decline in 2-6-Month-Old Infants Later Diagnosed with Autism. Frontiers in Public Health. 3: 272. PMID 26697420 DOI: 10.3389/Fpubh.2015.00272 |
0.222 |
|
2017 |
Purcell RH, Rommelfanger KS. Biometric Tracking From Professional Athletes to Consumers. The American Journal of Bioethics : Ajob. 17: 72-74. PMID 27996927 DOI: 10.1080/15265161.2016.1251652 |
0.213 |
|
2022 |
Robinson JT, Rommelfanger KS, Anikeeva PO, Etienne A, French J, Gelinas J, Grover P, Picard R. Building a culture of responsible neurotech: Neuroethics as socio-technical challenges. Neuron. PMID 35671759 DOI: 10.1016/j.neuron.2022.05.005 |
0.194 |
|
2017 |
Rommelfanger KS, Boshears PF. The Rubicon Already Crossed Ajob Neuroscience. 8: 197-199. DOI: 10.1080/21507740.2017.1392384 |
0.182 |
|
2014 |
Meltzer CC, Sze G, Rommelfanger KS, Kinlaw K, Banja JD, Wolpe PR. Guidelines for the ethical use of neuroimages in medical testimony: report of a multidisciplinary consensus conference. Ajnr. American Journal of Neuroradiology. 35: 632-7. PMID 23988754 DOI: 10.3174/ajnr.A3711 |
0.172 |
|
2020 |
Rommelfanger KS, Rapaport MH. Setting a Research Agenda for FND. Cns Spectrums. 1-3. PMID 33023700 DOI: 10.1017/S109285292000187X |
0.17 |
|
2023 |
Rommelfanger KS, Ramos KM, Salles A. Conceptual conundrums for neuroscience. Neuron. 111: 608-609. PMID 36863321 DOI: 10.1016/j.neuron.2023.02.016 |
0.165 |
|
2020 |
MacDuffie KE, Grubbs L, Best T, LaRoche S, Mildon B, Myers L, Stafford E, Rommelfanger KS. Stigma and FND: A Research Agenda Targeting the Clinical Encounter. Cns Spectrums. 1-19. PMID 33267932 DOI: 10.1017/S1092852920002084 |
0.128 |
|
2020 |
Rommelfanger KS. Reflecting on a Neuroethics Roadmap in a Global Crisis. Ajob Neuroscience. 11: 131-134. PMID 34029494 DOI: 10.1080/21507740.2020.1786311 |
0.111 |
|
2022 |
Taylor L, Rommelfanger KS. Mitigating white Western individualistic bias and creating more inclusive neuroscience. Nature Reviews. Neuroscience. 23: 389-390. PMID 35585252 DOI: 10.1038/s41583-022-00602-8 |
0.103 |
|
2017 |
Rommelfanger KS. The role of placebo in the diagnosis and treatment of functional neurologic disorders. Handbook of Clinical Neurology. 139: 607-617. PMID 27719875 DOI: 10.1016/B978-0-12-801772-2.00049-7 |
0.1 |
|
2023 |
Samudralwar RD, Jagolino-Cole A, Goss A, Rommelfanger KS. ANA Investigates Disruptive Technologies: Neuroethics Role in Advancing Innovation. Annals of Neurology. PMID 36692391 DOI: 10.1002/ana.26607 |
0.072 |
|
2019 |
Doraiswamy PM, London E, Varnum P, Harvey B, Saxena S, Tottman S, Campbell SP, Ibáñez AF, Manji H, Al Olama MAAS, Chou IH, Herrman H, Jeong SJ, Le T, Montojo C, ... ... Rommelfanger KS, et al. Empowering 8 Billion Minds: Enabling Better Mental Health for All via the Ethical Adoption of Technologies. Nam Perspectives. 2019. PMID 34532674 DOI: 10.31478/201910b |
0.064 |
|
Hide low-probability matches. |